loadpatents
Patent applications and USPTO patent grants for Linderoth; Lars.The latest application filed is for "co-agonists at glp-1 and gip receptors suitable for oral delivery".
Patent | Date |
---|---|
Co-agonists At Glp-1 And Gip Receptors Suitable For Oral Delivery App 20220177538 - Knerr; Patrick J. ;   et al. | 2022-06-09 |
Co-agonists At Glp-1 And Gip Receptors Suitable For Oral Delivery App 20220125940 - Knerr; Patrick James ;   et al. | 2022-04-28 |
Double-acylated GLP-1 derivatives Grant 11,117,947 - Wieczorek , et al. September 14, 2 | 2021-09-14 |
Double-acylated GLP-1 derivatives Grant 11,034,746 - Wieczorek , et al. June 15, 2 | 2021-06-15 |
GLP-1 derivatives and uses thereof Grant 10,946,074 - Kofoed , et al. March 16, 2 | 2021-03-16 |
Egf(a) Analogues With Fatty Acid Substituents App 20200407409 - Chen; Jianhe ;   et al. | 2020-12-31 |
EGF(A) analogues with fatty acid substituents Grant 10,822,385 - Chen , et al. November 3, 2 | 2020-11-03 |
Double-acylated GLP-1 compounds Grant 10,689,429 - Linderoth , et al. | 2020-06-23 |
Double-acylated Glp-1 Derivatives App 20200079834 - Wieczorek; Birgit ;   et al. | 2020-03-12 |
Glp-1 Derivatives And Uses Thereof App 20190038721 - Kofoed; Jacob ;   et al. | 2019-02-07 |
Egf(a) Analogues With Fatty Acid Substituents App 20190016768 - Chen; Jianhe ;   et al. | 2019-01-17 |
Double-Acylated GLP-1 Derivatives App 20180251512 - Wieczorek; Birgit ;   et al. | 2018-09-06 |
Double-acylated GLP-1 derivatives Grant 10,005,827 - Spetzler , et al. June 26, 2 | 2018-06-26 |
Acylated Glucagon Analogues App 20180016319 - Lau; Jesper F. ;   et al. | 2018-01-18 |
Double-acylated GLP-1 derivatives Grant 9,708,383 - Madsen , et al. July 18, 2 | 2017-07-18 |
Novel Glucagon Analogues App 20170190757 - Lau; Jesper F. ;   et al. | 2017-07-06 |
Double-Acylated GLP-1 Compounds App 20170114116 - Linderoth; Lars ;   et al. | 2017-04-27 |
Double-Acylated GLP-1 Derivatives App 20170058014 - Wieczorek; Birgit ;   et al. | 2017-03-02 |
Novel Glucagon Analogues App 20170051034 - Lau; Jesper F. ;   et al. | 2017-02-23 |
Double-acylated GLP-1 derivatives Grant 9,556,250 - Garibay , et al. January 31, 2 | 2017-01-31 |
Double-acylated GLP-1 derivatives Grant 9,527,900 - Linderoth , et al. December 27, 2 | 2016-12-27 |
Acylated Glucagon Analogues App 20160271263 - Lau; Jesper F. ;   et al. | 2016-09-22 |
Double-acylated Glp-1 Derivatives App 20160083447 - Wieczorek; Birgit ;   et al. | 2016-03-24 |
Double-acylated GLP-1 derivatives Grant 9,266,940 - Wieczorek , et al. February 23, 2 | 2016-02-23 |
Novel Glucagon Analogues App 20160002311 - Lau; Jesper F. ;   et al. | 2016-01-07 |
Acylated Glucagon Analogues App 20150274801 - Lau; Jesper F. ;   et al. | 2015-10-01 |
Double-Acylated GLP-1 Derivatives with a Linker App 20150210745 - Kofoed; Jacob ;   et al. | 2015-07-30 |
Double-acylated GLP-1 derivatives with a linker Grant 9,006,178 - Kofoed , et al. April 14, 2 | 2015-04-14 |
GLP-1 analogues and derivatives Grant 8,815,802 - Kalthoff , et al. August 26, 2 | 2014-08-26 |
Double-acylated Glp-1 Derivatives App 20140179899 - Garibay; Patrick William ;   et al. | 2014-06-26 |
Double-acylated Glp-1 Derivatives App 20140088005 - Wieczorek; Birgit ;   et al. | 2014-03-27 |
Double-acylated GLP-1 derivatives Grant 8,648,041 - Garibay , et al. February 11, 2 | 2014-02-11 |
Double-acylated Glp-1 Derivatives With A Linker App 20130338068 - Kofoed; Jacob ;   et al. | 2013-12-19 |
Double-Acylated GLP-1 Derivatives App 20130288960 - Madsen; Alice Ravn ;   et al. | 2013-10-31 |
Novel Glucagon Analogues App 20130143798 - Lau; Jesper F. ;   et al. | 2013-06-06 |
Glp-1 Analogues And Derivatives App 20130053311 - Kalthoff; Christoph ;   et al. | 2013-02-28 |
Novel Glucagon Analogues App 20130035285 - Lau; Jesper F. ;   et al. | 2013-02-07 |
Double-acylated Glp-1 Derivatives App 20110166321 - GARIBAY; PATRICK WILLIAM ;   et al. | 2011-07-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.